IM Therapeutics Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
IM Therapeutics is a biotechnology research company focused on developing therapies directed at human leukocyte antigens (HLAs) to treat autoimmune diseases. The firm is building an HLA-directed platform and has demonstrated early effectiveness in type 1 diabetes, with a pipeline aimed at targeted therapies across autoimmune conditions. Its customers are likely to be researchers and healthcare stakeholders seeking precision, first-in-class autoimmune treatments, addressing unmet needs in disease management. Based in Woburn, Massachusetts, the company operates in the biotechnology research sector and has pursued growth through a clinical-stage program and a leadership team with appointments in immunology and governance. A recent development includes advancing its clinical efforts with leadership hires and strategic milestones as part of its progression in precision medicine for autoimmune disease.